natural biocontrol in field conditions, a classic ex-
ample being the role of fluorescent pseudomonads
(P. fluorescens and P. putida) in suppressing the take-all
disease of cereals.
Control of fungal infections of humans
The control of fungal infections of humans presents
considerable difficulties, because often the patient is
severely compromised or immunosuppressed (Chap-
ter 16). It is worth noting that even the common
antibacterial antibiotics such as penicillins and
cephalosporins do not work alone; they act in con-
junction with the host’s normal defenses. There are,
however, several antimycotic agents that can be used
successfully to treat human mycoses (Odds et al. 2003).
We consider these below.
Griseofulvin
Griseofulvin (Fig. 17.11) is a naturally occurring anti-
fungal antibiotic, produced by the fungus Penicillium
griseofulvum. It is insoluble in water but can be taken
orally in a microcrystalline form and it then accumu-
lates in the keratin precursor cells of the skin, nails, and
hair. It is used almost exclusively to control the der-
matophyte infections of the keratinized tissues, but it
is fungistatic rather than fungicidal, so for serious
infections the treatment must be prolonged until all
the infected tissues have been shed.
As noted earlier, griseofulvin causes growth distor-
tions of fungal hyphae in spore germination tests,
including thickening of the hyphal walls, associated with
heavy deposition of glucans. However, this is now
known to be a secondary effect, and the primary role
of griseofulvin is to interfere with the assembly of
microtubules or of the tubulin-associated proteins. It
causes abnormal nuclear division by disrupting the
spindle microtubules, and abnormal growth, presumably
by disrupting the microtubule-associated transport of
materials to the hyphal tip. In these respects, the role
of griseofulvin is similar to that of the benzimidazole
fungicides used for plant disease control, because
these also block microtubule assembly. But the benz-
imidazoles evidently act at a different site on micro-
tubules because mutants that develop resistance to
the benzimidazoles are not resistant to griseofulvin, and
vice versa.
Griseofulvin has been the main drug used to
treat dermatophyte infections for many years, and
although resistance to the antibiotic can occur quite
frequently in vitro, it has not been a major problem in
clinical practice. However, griseofulvin is now being pro-
gressively replaced by newer synthetic drugs, includ-
ing terbinafine and itraconazole, which are less toxic
and require shorter treatment times.
350 CHAPTER 17
No. of plants No. of dominant % of isolates with
Crop examined bacterial isolates antifungal properties
Sugarbeet 1550 6780 38
Maize 503 1508 27
Soybean 450 1139 21
Sunflower 450 1119 22
Barley 36 175 92
Grape 36 231 100
Table 17.4Bacteria with antifungal
properties isolated by “nonselective”
methods from the root zone of crop
plants. (Adapted from Leyns et al.
1990.)
Griseofulvin Terbinafine
CH 2 CH 2
N CH 3
CH 3 CH 3
H
CH 3
C
C
H
C C C
OCH 3 OCH 3
CI CH 3
O
O
CH 3 O O
Fig. 17.11Structures of griseofulvin and terbinafine, two compounds used to treat dermatophyte infections.